nsc 338720 has been researched along with Breast Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riordan, JM; Struck, RF; Tiwari, A; Waud, WR | 1 |
Struck, R; Tiwari, A; Waud, W | 1 |
Struck, RF; Waud, WR | 1 |
Hartman, NR; O'Reilly, S; Schmid, SM; Shih, TW; Strong, JM; Struck, RF; Tiwari, A; Waud, WR | 1 |
Dykes, DJ; Griswold, DP; Harrison, SD; Plowman, J; Waud, WR | 1 |
5 other study(ies) available for nsc 338720 and Breast Neoplasms
Article | Year |
---|---|
Synthesis and antitumor activity of several new analogues of penclomedine and its metabolites.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Humans; Mice; Mice, Nude; Picolines; Structure-Activity Relationship; Thymidine; Xenograft Model Antitumor Assays | 2002 |
Determination of the phamacophore of penclomedine, a clinically-evaluated antitumor pyridine derivative.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chromatography, Thin Layer; Drug Screening Assays, Antitumor; Female; Humans; Indicators and Reagents; Mice; Mice, Nude; Neoplasm Transplantation; Picolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Thiolo-, thiono- and dithiocarbonate and thiocarbamate derivatives of demethylpenclomedine as novel anticancer agents.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Carbonates; Female; Humans; Mice; Mice, Nude; Picolines; Transplantation, Heterologous | 2006 |
4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine.
Topics: Animals; Antineoplastic Agents; Biotransformation; Breast Neoplasms; Humans; Leukemia P388; Male; Mice; Mice, Nude; Microsomes, Liver; Neoplasm Transplantation; Picolines; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Transplantation, Heterologous | 1997 |
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Picolines | 1991 |